Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)
China
· Delayed Price · Currency is CNY 9.94
+0.14 (1.43%)
Mar 10, 2026, 3:00 PM CST
SHA:603520 Revenue
Zhejiang Starry Pharmaceutical had revenue of 447.26M CNY in the quarter ending September 30, 2025, a decrease of -5.66%. This brings the company's revenue in the last twelve months to 2.39B, up 0.89% year-over-year. In the year 2024, Zhejiang Starry Pharmaceutical had annual revenue of 2.35B with 7.02% growth.
Revenue (ttm)
2.39B
Revenue Growth
+0.89%
P/S Ratio
1.82
Revenue / Employee
1.36M
Employees
1,754
Market Cap
4.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.35B | 154.24M | 7.02% |
| Dec 31, 2023 | 2.20B | 64.75M | 3.04% |
| Dec 31, 2022 | 2.13B | 131.32M | 6.57% |
| Dec 31, 2021 | 2.00B | 632.83M | 46.29% |
| Dec 31, 2020 | 1.37B | 58.25M | 4.45% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinotherapeutics | 446.50M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 619.88M |
| Shanghai Xiao Fang Pharmaceutical | 504.59M |
| Tibet AIM Pharm. | 628.02M |
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Qianjiang Yongan Pharmaceutical | 797.25M |
| Yabao Pharmaceutical Group | 2.27B |